450330.KQ
Hass
KOE · Healthcare · Medical - Specialties · KR
KRW 4,085.00
−0.97%Year over year
Reported trailing growth
- Revenue
- +2.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +94.4%
- Operating cash flow
- +1430.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.6%
- EBITDA
- -52.1%
- EBIT
- —
- Net income
- -16.3%
- EPS
- -24.6%
- Free cash flow
- +93.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026